← FDA ENFORCEMENT
D-0576-2026Class II

Guardian Drug Co. Inc.

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Guardian Drug Co. Inc.
Product type
Drug
Status
Ongoing
Report date
2026-06-10
Distribution
U.S.A. Nationwide
Firm state
NJ
Initiated by
Voluntary: Firm initiated
Reason for recall

Presence of foreign substance: small metallic particles in chewable tablets.

Product description

EQUALINE extra strength, antacid tablets, calcium carbonate 750mg, 96 chewable tablets, DISTRIBUTED BY SUPERVALU INC.,EDEN PRARIE, MN 55344 USA, NDC 41163-129-22.

Code / lot info

Lot #: 1276118, expires: JAN- 2029.

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →